Building on the success of previous meetings, the conference will feature invited lectures, debates, poster sessions and oral abstract sessions focusing on topics such as paraneoplastic and immune disorders associated with thymic malignancies, establishment of cell lines from thymic tumors, development of gene signatures to determine prognosis, multimodality treatment of thymoma and thymic carcinoma and emerging drug targets and the role of targeted therapy in the treatment of these cancers. The Conference will provide the ideal forum to stimulate ideas and establish collaborations as well as to initiate intense discussions about the role of clinical trials, surgery, radiation therapy and other novel approaches for the treatment of thymic cancers. Poster viewing opportunities and interactive oral abstract sessions will foster communications between delegates.
ITMIG 2017 values the building of relationships throughout the meeting. Going beyond the formal scientific sessions, ITMIG encourages building all relationships, including between continents, specialties and particularly also between industry sponsors and ITMIG members.
The Conference is undoubtedly the best opportunity for networking, sharing the latest information and discussions with the world’s leading experts in this field.
|Thursday, September 21||18:30 – 19:30|
|Friday, September 22||10:00 – 15:30|
|Saturday, September 23||10:30 – 16:00|
ITMIG 2017 Conference Manager
International Conference Services Ltd. (ICS)
Phone: +1 604 681 2153
Email: itmig2017 at icsevents.com